Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylnaltrexone for Post Operative Ileus
NCT00387309Phase 3Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of methylnaltrexone in postoperative ileus (POI), sponsored by Valeant Pharmaceuticals. Started Dec 2006; status: completed.
02
Drugs
methylnaltrexone
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on NCT00387309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00387309.